IL96782A - Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs - Google Patents

Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs

Info

Publication number
IL96782A
IL96782A IL9678290A IL9678290A IL96782A IL 96782 A IL96782 A IL 96782A IL 9678290 A IL9678290 A IL 9678290A IL 9678290 A IL9678290 A IL 9678290A IL 96782 A IL96782 A IL 96782A
Authority
IL
Israel
Prior art keywords
compound
formula
afford
amino
defined above
Prior art date
Application number
IL9678290A
Other languages
English (en)
Hebrew (he)
Other versions
IL96782A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL96782A0 publication Critical patent/IL96782A0/xx
Publication of IL96782A publication Critical patent/IL96782A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9678290A 1989-12-27 1990-12-25 Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs IL96782A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45761089A 1989-12-27 1989-12-27
US59449790A 1990-10-09 1990-10-09

Publications (2)

Publication Number Publication Date
IL96782A0 IL96782A0 (en) 1991-09-16
IL96782A true IL96782A (en) 1994-10-21

Family

ID=27038667

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9678290A IL96782A (en) 1989-12-27 1990-12-25 Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs

Country Status (13)

Country Link
EP (1) EP0435222A3 (hu)
JP (1) JPH085861B2 (hu)
KR (1) KR100190783B1 (hu)
AU (1) AU631953B2 (hu)
CA (1) CA2032973A1 (hu)
CZ (1) CZ282665B6 (hu)
HU (1) HUT56347A (hu)
IE (1) IE904679A1 (hu)
IL (1) IL96782A (hu)
NO (1) NO905543L (hu)
PL (1) PL288420A1 (hu)
PT (1) PT96363A (hu)
YU (1) YU244990A (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902312A (en) * 1989-01-30 1990-02-20 Allied-Signal Inc. Carbon molecular sieves for purification of chlorofluorocarbons
EP0642499A1 (en) * 1991-09-24 1995-03-15 Pfizer Inc. Retinoids and their use in treating skin diseases and leukemia
US6031105A (en) * 1996-04-09 2000-02-29 Pfizer Inc Substituted pyridines
US6008361A (en) * 1996-04-09 1999-12-28 Pfizer Inc. Substituted pyridines
ES2203762T3 (es) * 1996-11-14 2004-04-16 Pfizer Inc. Piridinas intermedias utiles en la sintesis de agonistas del receptor adrenergico beta.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6604123A (hu) * 1965-05-28 1966-11-29
DE2617101A1 (de) * 1976-04-17 1977-11-17 Thomae Gmbh Dr K Neue naphthyridine
DE3641698A1 (de) * 1986-04-29 1987-11-05 Basf Ag Verfahren zur herstellung von heteroaromatischen aminoaldehyden
US5051430A (en) * 1990-09-10 1991-09-24 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1H-indazol-3-yl)-4-pyridinamines

Also Published As

Publication number Publication date
EP0435222A2 (en) 1991-07-03
IL96782A0 (en) 1991-09-16
HUT56347A (en) 1991-08-28
NO905543D0 (no) 1990-12-21
PL288420A1 (en) 1992-06-15
EP0435222A3 (en) 1991-12-11
KR910011792A (ko) 1991-08-07
CZ658590A3 (en) 1997-05-14
JPH05345762A (ja) 1993-12-27
JPH085861B2 (ja) 1996-01-24
PT96363A (pt) 1991-09-30
NO905543L (no) 1991-06-28
KR100190783B1 (ko) 1999-06-01
YU244990A (sh) 1993-05-28
IE904679A1 (en) 1991-07-17
HU908403D0 (en) 1991-07-29
CZ282665B6 (cs) 1997-08-13
AU6840990A (en) 1991-07-04
CA2032973A1 (en) 1991-06-28
AU631953B2 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
SK70899A3 (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
US5059602A (en) 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
EP0477903B1 (en) Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments
IL96782A (en) Aminopyridinylmethanol and aminomethylpyridinamines and similar compounds, a process for their preparation and use as drugs
US5095019A (en) 4-substituted dihydropyrido(4,3-D)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US5414004A (en) Neurotransmitter releasers useful for cognition enhancement
IE902330L (en) Naphthylamino-and napththyloxy-pyridinamines
US5055476A (en) 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives
EP0094422B1 (en) Substituted pyridines
EP0475352B1 (en) 3-(1H-Indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments
US5039811A (en) Preparation of N-(pyridinyl)-1H-indol-1-amines
US5166163A (en) 3-(1H-indazol-3-yl)-4-pyridinamines
US5532247A (en) Neurotransmitter releasers useful for cognition enhancement
MXPA99007937A (en) Quinoxalinediones

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees